As of 2026-01-08, the Relative Valuation of Arcutis Biotherapeutics Inc (ARQT) is (9.16) USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.58 USD, the upside of Arcutis Biotherapeutics Inc based on Relative Valuation is -131.0%.
The range of the Relative Valuation is (6.84) - (9.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 26.3x | 22.5x |
| Forward P/E multiples | 18.9x - 37.5x | 28.2x |
| Fair Price | (6.84) - (9.52) | (9.16) |
| Upside | -123.1% - -132.2% | -131.0% |
| Date | P/E |
| 2026-01-05 | -83.46 |
| 2026-01-02 | -80.14 |
| 2025-12-31 | -80.25 |
| 2025-12-30 | -77.60 |
| 2025-12-29 | -78.93 |
| 2025-12-26 | -80.06 |
| 2025-12-24 | -81.39 |
| 2025-12-23 | -81.00 |
| 2025-12-22 | -82.63 |
| 2025-12-19 | -77.41 |
| 2025-12-18 | -76.77 |
| 2025-12-17 | -78.32 |
| 2025-12-16 | -78.84 |
| 2025-12-15 | -80.00 |
| 2025-12-12 | -80.20 |
| 2025-12-11 | -81.44 |
| 2025-12-10 | -82.27 |
| 2025-12-09 | -82.24 |
| 2025-12-08 | -85.75 |
| 2025-12-05 | -86.22 |
| 2025-12-04 | -86.11 |
| 2025-12-03 | -82.79 |
| 2025-12-02 | -81.33 |
| 2025-12-01 | -83.93 |
| 2025-11-28 | -84.70 |
| 2025-11-26 | -85.56 |
| 2025-11-25 | -84.92 |
| 2025-11-24 | -85.01 |
| 2025-11-21 | -81.50 |
| 2025-11-20 | -75.53 |
| 2025-11-19 | -77.07 |
| 2025-11-18 | -75.39 |
| 2025-11-17 | -72.32 |
| 2025-11-14 | -69.09 |
| 2025-11-13 | -63.17 |
| 2025-11-12 | -64.80 |
| 2025-11-11 | -66.41 |
| 2025-11-10 | -65.63 |
| 2025-11-07 | -66.96 |
| 2025-11-06 | -69.36 |
| 2025-11-05 | -67.37 |
| 2025-11-04 | -66.35 |
| 2025-11-03 | -68.42 |
| 2025-10-31 | -69.94 |
| 2025-10-30 | -68.87 |
| 2025-10-29 | -69.89 |
| 2025-10-28 | -68.95 |
| 2025-10-27 | -54.28 |
| 2025-10-24 | -55.57 |
| 2025-10-23 | -55.49 |